• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清杀菌试验作为囊性纤维化急性肺部加重期的预后指标

Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.

作者信息

Cahen P, Le Bourgeois M, Delacourt C, Coustère C, Nicaise P, de Blic J, Véron M, Scheinmann P, Gaillard J L

机构信息

Department of Microbiology, Hôpital Necker-Enfants Malades, Paris, France.

出版信息

Pediatrics. 1993 Feb;91(2):451-5.

PMID:8424026
Abstract

The serum bactericidal test has been used for many years for optimal assessment of the efficacy of antibiotic therapy in patients with infective endocarditis and other bacterial infections. Its capacity to predict the bacteriological outcome of acute pulmonary exacerbations in patients with cystic fibrosis was evaluated. A total of 54 courses of intravenous antibiotic therapy were analyzed in 22 patients, whose ages ranged from 4 months to 24 years (mean age: 10 years). The serum bactericidal activity of blood samples, taken at expected peak and trough antibiotic levels on day 4 of therapy, were determined against the potentially pathogenic strains isolated in sputum at the time of admission. For 104 isolates (64 Pseudomonas aeruginosa, 28 Staphylococcus aureus, and 12 Haemophilus influenzae strains), the peak and trough bactericidal titers were compared to bacteriological outcome. Bacteriological success was defined as a decrease of 2 log10 units or more in the bacterial density in sputum between days 0 and 7 of therapy. At peak antibiotic levels, serum bactericidal titers of 1:128 or more were 96% (all isolates) and 89% (P aeruginosa isolates), predictive of cure, whereas serum bactericidal titers of less than 1:16 were 100% predictive of failure for all infecting bacteria. In patients aged less than 18 years, the best peak titer for predicting success was 1:64, with a predictive value of 96% for titers of 1:64 or greater. The peak titer that best predicted success in patients aged 18 years or more was 1:128, with a predictive value of only 83% for titers of 1:128 or greater.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

血清杀菌试验多年来一直用于最佳评估感染性心内膜炎和其他细菌感染患者抗生素治疗的疗效。本研究评估了其预测囊性纤维化患者急性肺部加重细菌学转归的能力。共分析了22例年龄从4个月至24岁(平均年龄:10岁)患者的54个静脉抗生素治疗疗程。在治疗第4天,采集预期抗生素血药浓度峰值和谷值时的血样,测定其针对入院时痰液中分离出的潜在致病菌株的血清杀菌活性。针对104株分离菌(64株铜绿假单胞菌、28株金黄色葡萄球菌和12株流感嗜血杆菌),比较其峰值和谷值杀菌滴度与细菌学转归情况。细菌学成功定义为治疗第0天至第7天痰液中细菌密度降低2个对数单位或更多。在抗生素血药浓度峰值时,血清杀菌滴度≥1:128对所有分离菌的治愈率预测率为96%,对铜绿假单胞菌分离菌的治愈率预测率为89%,而血清杀菌滴度<1:16对所有感染细菌的治疗失败预测率为100%。在年龄<18岁的患者中,预测成功的最佳峰值滴度为1:64,滴度≥1:64时预测值为96%。在年龄≥18岁的患者中,预测成功的最佳峰值滴度为1:128,滴度≥1:128时预测值仅为83%。(摘要截短于250字)

相似文献

1
Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.血清杀菌试验作为囊性纤维化急性肺部加重期的预后指标
Pediatrics. 1993 Feb;91(2):451-5.
2
Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.β-内酰胺类药物体外活性与囊性纤维化急性肺部加重期细菌学转归的相关性
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):291-6. doi: 10.1007/BF02116521.
3
Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Pediatrics. 1977 Sep;60(3):372-7.
4
Use of serum bactericidal activity in assessing previous antibiotic therapy in acute lower respiratory tract infection in children.
Southeast Asian J Trop Med Public Health. 1995 Dec;26(4):639-41.
5
Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.囊性纤维化患者在抗生素治疗前后痰液中的细胞因子水平。
Pediatr Pulmonol. 2005 Jul;40(1):15-21. doi: 10.1002/ppul.20237.
6
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.丹麦、挪威和瑞典囊性纤维化中心铜绿假单胞菌的患病率及治疗差异。
J Cyst Fibros. 2009 Mar;8(2):135-42. doi: 10.1016/j.jcf.2008.11.001. Epub 2009 Jan 20.
7
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.囊性纤维化患者病情加重期间的耐抗生素专性厌氧菌
Clin Microbiol Infect. 2009 May;15(5):454-60. doi: 10.1111/j.1469-0691.2008.02659.x. Epub 2009 Jan 22.
8
Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.成人囊性纤维化患者住院与居家静脉注射抗生素治疗的比较。
J Clin Nurs. 2006 Jan;15(1):52-60. doi: 10.1111/j.1365-2702.2005.01236.x.
9
[Antibiotic treatment of cystic fibrosis].[囊性纤维化的抗生素治疗]
Ann Pediatr (Paris). 1991 Oct;38(8):523-8.
10
A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.生物膜抗生素敏感性测试的回顾性分析:囊性纤维化急性加重期临床反应的更好预测指标
J Cyst Fibros. 2009 Mar;8(2):122-7. doi: 10.1016/j.jcf.2008.10.005. Epub 2008 Dec 7.

引用本文的文献

1
Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases.多粘菌素联合治疗及血清杀菌效价在产KPC肺炎克雷伯菌感染管理中的应用:3例报告
Case Rep Med. 2011;2011:659769. doi: 10.1155/2011/659769. Epub 2011 Nov 28.
2
Peritoneal fluid titer test for peritoneal dialysis-related peritonitis.用于腹膜透析相关性腹膜炎的腹水滴度试验。
Antimicrob Agents Chemother. 2004 May;48(5):1719-26. doi: 10.1128/AAC.48.5.1719-1726.2004.
3
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.
死菌不会变异:细菌耐药性产生中的易感性问题。
Emerg Infect Dis. 2003 Jan;9(1):10-6. doi: 10.3201/eid0901.020172.
4
Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis.囊性纤维化患儿假单胞菌感染的防控前景
Paediatr Drugs. 2000 Nov-Dec;2(6):451-63. doi: 10.2165/00128072-200002060-00004.
5
Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.β-内酰胺类药物体外活性与囊性纤维化急性肺部加重期细菌学转归的相关性
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):291-6. doi: 10.1007/BF02116521.